Análisis de costo-efectividad de nilotinib, dasatinib e imatinib como terapia de primera línea en leucemia mieloide crónica en Colombia, 2012-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Análisis de costo-efectividad de nilotinib, dasatinib e imatinib como terapia de primera línea en leucemia mieloide crónica en Colombia, 2012

Published:2013-08-13 Issue:1 Volume:34 Page:48
ISSN:0120-4157
Container-title:Biomédica
language:
Short-container-title:biomedica

Author:

Romero Martín,Chávez Diana,De los Ríos Magalí,Alvis-Guzmán Nelson

Publisher

Instituto Nacional de Salud (Colombia)

Subject

General Biochemistry, Genetics and Molecular Biology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does platelet aggregation differ among chronic myeloid leukemia-chronic phase (CML-CP) patients on tyrosine kinase inhibitors (TKIs)? A tertiary center experience;The Egyptian Journal of Haematology;2023-04

2. A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia;PharmacoEconomics;2022-09-30

3. Plasma Level of Programmed Death Receptor Ligand-1 and CD25 in Chronic Myeloid Leukemia Patients and their Correlations with Response to First-Line Therapy;Medical Journal of Babylon;2021-10

4. Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries;Cost Effectiveness and Resource Allocation;2021-03-12

5. Dos décadas de economía de la salud en Colombia;Cuadernos de Economía;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP